Multicenter Study of Hydroxyurea in Patients With Sickle Cell Anemia (MSH)

This study has been completed.
Information provided by National Heart, Lung, and Blood Institute (NHLBI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Anemia, Sickle Cell
			Hematologic Diseases
			Hemoglobinopathies
2		Additional conditions recognized in this trial
			Anemia
3		More general conditions related to this trial
			Anemia, Hemolytic
			Anemia, Hemolytic, Congenital
			Genetic Diseases, Inborn
4		Interventions listed in this trial
			hydroxyurea
5		More general drug interventions related to this trial
			Antineoplastic Agents
			Antisickling Agents
			Enzyme Inhibitors
			Hematologic Agents
			Molecular Mechanisms of Pharmacological Action
			Nucleic Acid Synthesis Inhibitors
			Pharmacologic Actions
			Therapeutic Uses
6		Sponsors listed in this trial
			National Heart, Lung, and Blood Institute (NHLBI)